Correction: Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Saved in:
Format: | article |
---|---|
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/891690c79fb34bd2a5beff02a9ca97bb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
by: Karachaliou N, et al.
Published: (2014) -
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
by: Suda K, et al.
Published: (2013) -
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
by: Barbara Melosky, et al.
Published: (2021) -
Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
by: Xiaoying Zhang
Published: (2021) -
Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
by: Karan Seegobin, et al.
Published: (2021)